Michael C. Myers

1.4k total citations
30 papers, 991 citations indexed

About

Michael C. Myers is a scholar working on Molecular Biology, Organic Chemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael C. Myers has authored 30 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael C. Myers's work include RNA and protein synthesis mechanisms (8 papers), Protease and Inhibitor Mechanisms (4 papers) and Cardiomyopathy and Myosin Studies (4 papers). Michael C. Myers is often cited by papers focused on RNA and protein synthesis mechanisms (8 papers), Protease and Inhibitor Mechanisms (4 papers) and Cardiomyopathy and Myosin Studies (4 papers). Michael C. Myers collaborates with scholars based in United States, Sweden and Germany. Michael C. Myers's co-authors include Daniel H. Appella, Toshiaki HARA, Jin‐Quan Yu, Donna M. Huryn, Tao Liu, Stewart R. Durell, Scott L. Diamond, Amos B. Smith, Ashwin R. Bharadwaj and Karl A. Scheidt and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Michael C. Myers

30 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael C. Myers United States 17 443 420 126 83 73 30 991
William E. Bauta United States 14 588 1.3× 232 0.6× 164 1.3× 47 0.6× 49 0.7× 25 1.1k
Yasheen Zhou United States 15 623 1.4× 418 1.0× 108 0.9× 81 1.0× 50 0.7× 25 1.1k
Konrad Misiura Poland 16 381 0.9× 390 0.9× 65 0.5× 58 0.7× 18 0.2× 67 817
Alka Agarwal India 17 666 1.5× 366 0.9× 72 0.6× 36 0.4× 65 0.9× 64 1.0k
Yong-Kang Zhang China 16 388 0.9× 353 0.8× 103 0.8× 160 1.9× 42 0.6× 27 924
Marcella Bassetto United Kingdom 19 435 1.0× 272 0.6× 222 1.8× 139 1.7× 37 0.5× 54 1.0k
Marco A. Biamonte United States 14 246 0.6× 602 1.4× 139 1.1× 146 1.8× 21 0.3× 27 1.1k
John A. McCauley United States 19 725 1.6× 517 1.2× 237 1.9× 59 0.7× 51 0.7× 33 1.4k
Marco Persico Italy 22 524 1.2× 587 1.4× 82 0.7× 209 2.5× 23 0.3× 59 1.4k
Neelima Mondal India 16 159 0.4× 432 1.0× 70 0.6× 61 0.7× 146 2.0× 26 762

Countries citing papers authored by Michael C. Myers

Since Specialization
Citations

This map shows the geographic impact of Michael C. Myers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Myers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Myers more than expected).

Fields of papers citing papers by Michael C. Myers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Myers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Myers. The network helps show where Michael C. Myers may publish in the future.

Co-authorship network of co-authors of Michael C. Myers

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Myers. A scholar is included among the top collaborators of Michael C. Myers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Myers. Michael C. Myers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Myers, Michael C., et al.. (2025). Prevalence and Incidence of Dilated Cardiomyopathy in the United States and Western Europe: A Systematic Review. Cardiology Research. 16(4). 295–305. 1 indexed citations
2.
Myers, Michael C., Su Wang, Yue Zhong, et al.. (2024). Prevalence of Genetically Associated Dilated Cardiomyopathy: A Systematic Literature Review and Meta-Analysis. Cardiology Research. 15(4). 233–245. 2 indexed citations
3.
Myers, Michael C., et al.. (2024). Diverse Concepts in Definitions of Dilated Cardiomyopathy: Theory and Practice. Cardiology Research. 15(5). 319–329. 1 indexed citations
4.
Rajasekaran, Deepa, Yuval Blat, Michael C. Myers, et al.. (2023). HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin. SLAS DISCOVERY. 28(5). 223–232. 6 indexed citations
5.
Myers, Michael C., Cullen L. Cavallaro, Shun Su, et al.. (2020). Discovery and SAR of aryl hydroxy pyrimidinones as potent small molecule agonists of the GPCR APJ. Bioorganic & Medicinal Chemistry Letters. 30(7). 126955–126955. 10 indexed citations
6.
Liu, Tao, Michael C. Myers, & Jin‐Quan Yu. (2016). Copper‐Catalyzed Bromination of C(sp3)−H Bonds Distal to Functional Groups. Angewandte Chemie International Edition. 56(1). 306–309. 104 indexed citations
7.
Liu, Tao, Michael C. Myers, & Jin‐Quan Yu. (2016). Copper‐Catalyzed Bromination of C(sp3)−H Bonds Distal to Functional Groups. Angewandte Chemie. 129(1). 312–315. 31 indexed citations
8.
Gillespie, Paul, Michael C. Myers, Karin Conde‐Knape, et al.. (2014). Discovery of camphor-derived pyrazolones as 11β-hydroxysteroid dehydrogenase type 1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(12). 2707–2711. 2 indexed citations
9.
Gillespie, Paul, Robert A. Goodnow, Gopal Bose, et al.. (2013). Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 24(3). 949–953. 13 indexed citations
10.
Shah, Parag P., Tianhua Wang, Rachel Kaletsky, et al.. (2010). A Small-Molecule Oxocarbazate Inhibitor of Human Cathepsin L Blocks Severe Acute Respiratory Syndrome and Ebola Pseudotype Virus Infection into Human Embryonic Kidney 293T cells. Molecular Pharmacology. 78(2). 319–324. 98 indexed citations
11.
Lucumi, Edinson, Michael C. Myers, Andrew D. Napper, et al.. (2010). Identification of Novel Inhibitors of Dietary Lipid Absorption Using Zebrafish. PLoS ONE. 5(8). e12386–e12386. 76 indexed citations
12.
Shah, Parag P., Michael C. Myers, Mary Pat Beavers, et al.. (2008). Kinetic Characterization and Molecular Docking of a Novel, Potent, and Selective Slow-Binding Inhibitor of Human Cathepsin L. Molecular Pharmacology. 74(1). 34–41. 33 indexed citations
13.
Myers, Michael C., Parag P. Shah, Mary Pat Beavers, et al.. (2008). Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype. Bioorganic & Medicinal Chemistry Letters. 18(12). 3646–3651. 15 indexed citations
14.
Johnston, Paul A., Jennifer Phillips, Tong Ying Shun, et al.. (2007). HTS Identifies Novel and Specific Uncompetitive Inhibitors of the Two-Component NS2B-NS3 Proteinase of West Nile Virus. Assay and Drug Development Technologies. 5(6). 737–750. 85 indexed citations
15.
Myers, Michael C., Andrew D. Napper, Nuzhat Motlekar, et al.. (2007). Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: The confounding effects of DTT and cysteine in biological assays. Bioorganic & Medicinal Chemistry Letters. 17(17). 4761–4766. 21 indexed citations
16.
Myers, Michael C., Parag P. Shah, Scott L. Diamond, Donna M. Huryn, & Amos B. Smith. (2007). Identification and synthesis of a unique thiocarbazate cathepsin L inhibitor. Bioorganic & Medicinal Chemistry Letters. 18(1). 210–214. 20 indexed citations
17.
HARA, Toshiaki, Stewart R. Durell, Michael C. Myers, & Daniel H. Appella. (2006). Probing the Structural Requirements of Peptoids That Inhibit HDM2−p53 Interactions. Journal of the American Chemical Society. 128(6). 1995–2004. 133 indexed citations
18.
Myers, Michael C., et al.. (2005). A New Family of Small Molecules To Probe the Reactivation of Mutant p53. Journal of the American Chemical Society. 127(17). 6152–6153. 63 indexed citations
19.
Myers, Michael C., Jonathan K. Pokorski, & Daniel H. Appella. (2004). Peptide Nucleic Acids with a Flexible Secondary Amine in the Backbone Maintain Oligonucleotide Binding Affinity. Organic Letters. 6(25). 4699–4702. 20 indexed citations
20.
Myers, Michael C., Natalie Larionova, John M. Franck, et al.. (2003). A Cyclopentane Conformational Restraint for a Peptide Nucleic Acid:  Design, Asymmetric Synthesis, and Improved Binding Affinity to DNA and RNA. Organic Letters. 5(15). 2695–2698. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William E. Bauta Breakdown of academic impact, for papers by Yasheen Zhou Breakdown of academic impact, for papers by Konrad Misiura Breakdown of academic impact, for papers by Alka Agarwal Breakdown of academic impact, for papers by Yong-Kang Zhang Breakdown of academic impact, for papers by Marcella Bassetto Breakdown of academic impact, for papers by Marco A. Biamonte Breakdown of academic impact, for papers by John A. McCauley Breakdown of academic impact, for papers by Marco Persico Breakdown of academic impact, for papers by Neelima Mondal
Rankless by CCL
2026